NasdaqGS - Delayed Quote USD

Schrödinger, Inc. (SDGR)

23.97 +0.63 (+2.70%)
At close: April 26 at 4:00 PM EDT
24.25 +0.28 (+1.17%)
After hours: April 26 at 7:29 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
216,666.00
216,666.00
180,955.00
137,931.00
108,095.00
Cost of Revenue
75,974.00
75,974.00
79,933.00
72,311.00
44,623.00
Gross Profit
140,692.00
140,692.00
101,022.00
65,620.00
63,472.00
Operating Expense
318,140.00
318,140.00
247,839.00
177,063.00
124,388.00
Operating Income
-177,448.00
-177,448.00
-146,817.00
-111,443.00
-60,916.00
Net Non Operating Interest Income Expense
--
--
--
1,057.00
2,253.00
Other Income Expense
220,367.00
220,367.00
-2,309.00
10,635.00
34,624.00
Pretax Income
42,919.00
42,919.00
-149,126.00
-100,808.00
-26,292.00
Tax Provision
2,199.00
2,199.00
63.00
411.00
345.00
Net Income Common Stockholders
40,720.00
40,720.00
-149,186.00
-100,393.00
-24,463.00
Diluted NI Available to Com Stockholders
40,720.00
40,720.00
-149,186.00
-100,393.00
-24,463.00
Basic EPS
0.57
--
-2.10
-1.42
-0.41
Diluted EPS
0.54
--
-2.10
-1.42
-0.41
Basic Average Shares
71,776.30
--
71,173.42
70,594.95
60,024.66
Diluted Average Shares
74,986.82
--
71,173.42
70,594.95
60,024.66
Total Operating Income as Reported
-177,448.00
-177,448.00
-146,817.00
-111,443.00
-60,916.00
Total Expenses
394,114.00
394,114.00
327,772.00
249,374.00
169,011.00
Net Income from Continuing & Discontinued Operation
40,720.00
40,720.00
-149,186.00
-100,393.00
-24,463.00
Normalized Income
-10,001.87
-10,001.87
-134,899.64
-108,685.07
-45,094.99
Interest Income
--
--
--
1,057.00
2,253.00
Net Interest Income
--
--
--
1,057.00
2,253.00
EBIT
-177,448.00
-177,448.00
-146,817.00
-111,443.00
-60,916.00
EBITDA
-171,896.00
-171,896.00
-142,473.00
-108,596.00
-57,258.00
Reconciled Cost of Revenue
75,974.00
75,974.00
79,933.00
72,311.00
44,623.00
Reconciled Depreciation
5,552.00
5,552.00
4,344.00
2,847.00
3,658.00
Net Income from Continuing Operation Net Minority Interest
40,720.00
40,720.00
-149,186.00
-100,393.00
-24,463.00
Total Unusual Items Excluding Goodwill
53,461.00
53,461.00
-18,084.00
11,359.00
28,263.00
Total Unusual Items
53,461.00
53,461.00
-18,084.00
11,359.00
28,263.00
Normalized EBITDA
-225,357.00
-225,357.00
-124,389.00
-119,955.00
-85,521.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
2,739.13
2,739.13
-3,797.64
3,066.93
7,631.01
12/31/2020 - 2/6/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CERT Certara, Inc.
16.57
+1.66%
 
TDOC Teladoc Health, Inc.
13.01
-2.40%
 
TXG 10x Genomics, Inc.
27.59
+2.57%
 
ACCD Accolade, Inc.
7.89
-14.15%
 
GDRX GoodRx Holdings, Inc.
7.19
+1.55%
 
DOCS Doximity, Inc.
23.82
+0.97%
 
VEEV Veeva Systems Inc.
200.91
+0.91%
 
PGNY Progyny, Inc.
32.04
-1.42%
 
GEHC GE HealthCare Technologies Inc.
86.24
+0.34%
 
LFMD LifeMD, Inc.
11.95
+10.44%